Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P51532 (
transcriptional activator
)
6,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
GAL4
is a
transcriptional activator
of the galactose metabolism genes in the yeast Saccharomyces cerevisiae. We show that
GAL4
expressed in yeast activated transcription equally well when a single
GAL4
binding site was placed at any of nine positions upstream of the GAL1 (galactokinase gene) "TATA box." We chose a sufficient number of positions for the binding site to ensure that, in several of these positions,
GAL4
was on the opposite side of the DNA helix with respect to the TATA box. Smaller
GAL4
derivatives were similar to wild-type
GAL4
in that they also activated transcription in a manner independent of the side of the DNA helix they bound with respect to the TATA box. Unlike wild-type
GAL4
, however, these smaller
GAL4
derivatives activated transcription better when we placed a binding site progressively closer to the TATA box over a distance of 34 base pairs.
...
PMID:No strict alignment is required between a transcriptional activator binding site and the "TATA box" of a yeast gene. 313 8
GAL4
is a
transcriptional activator
found in yeast. Two distinct functions of the protein are required for its activity: one directs sequence-specific DNA binding, and another interacts with some other component of the transcriptional machinery, for example, RNA polymerase II or a TATA-binding protein. Two short regions of
GAL4
function as 'activating sequences' when attached to the DNA-binding portion of
GAL4
and these regions can be replaced by a large number of peptides encoded by Escherichia coli genomic DNA fragments or by a synthetic peptide designed to form an amphiphilic alpha-helix. All of these activating sequences, like that found in another yeast activator, GCN4 bear an excess negative charge.
GAL4
and its derivatives that are active in yeast stimulate transcription in mammalian cells when
GAL4
binding sites are introduced upstream of a mammalian gene; similarly,
GAL4
activates transcription in Drosophila cells. Here we show that
GAL4
derivatives stimulate gene expression in plant cells.
...
PMID:Yeast activators stimulate plant gene expression. 316 94
GAL80, an inhibitor of the yeast
transcriptional activator
GAL4
, is converted into an activator by inserting an acidic activating sequence into it. This hybrid activator does not bind to DNA directly, but is brought to DNA by interacting with a derivative of
GAL4
that interacts with both DNA and GAL80.
...
PMID:Converting a eukaryotic transcriptional inhibitor into an activator. 318 Feb 18
In wild-type yeast the action of the
transcriptional activator
GAL4
is inhibited by GAL80, and galactose relieves this inhibition. We show that deletion mutants of
GAL4
lacking 30 amino acids of the carboxyl terminus activate transcription constitutively, whereas other deletion mutants bearing the carboxy-terminal 30 amino acids are inhibited by GAL80. Moreover,
GAL4
fragments bearing these 30 amino acids, when expressed from a strong promoter on multicopy plasmids, free the endogenous
GAL4
from inhibition by GAL80. These and other results suggest that GAL80 recognizes the carboxy-terminal 30 amino acids of
GAL4
, forming a complex that, though bound to DNA, does not activate transcription.
...
PMID:The carboxy-terminal 30 amino acids of GAL4 are recognized by GAL80. 329 49
UV light can serve as a molecular probe to identify DNA-protein interactions at nucleotide level resolution from intact yeast cells. We have used the photofootprinting technique to determine during which of three regulated states (uninduced, induced, and catabolite repressed) the
transcriptional activator
protein encoded by
GAL4
binds to its recognition sites within the GAL1-GAL10 upstream activating sequence (UASG).
GAL4
protein is bound to at least four, and probably five, related sequence blocks within UASG under both induced and uninduced states.
GAL4
-dependent photofootprints are lost under conditions of catabolite repression. We observed no footprint patterns unique to catabolite-repressed cells, which suggests that binding of a repressor to the UASG is not involved in this process. Photofootprints of the GAL10 TATA element are strictly correlated with transcription: uninduced, catabolite-repressed, and delta gal4 cells exhibit footprints characteristic of the inactive promoter; induced and delta gal80 cells, which express GAL10 constitutively, display footprints unique to the actively transcribed gene.
...
PMID:In vivo DNA-binding properties of a yeast transcription activator protein. 331 11
The yeast
transcriptional activator
GAL4
binds specific sites on DNA to activate transcription of adjacent genes. The distinct activating regions of
GAL4
are rich in acidic residues and it has been suggested that these regions interact with another protein component of the transcriptional machinery (such as the TATA-binding protein or RNA polymerase II) while the DNA-binding region serves to position the activating region near the gene. Here we show that various
GAL4
derivatives, when expressed at high levels in yeast, inhibit transcription of certain genes lacking
GAL4
binding sites, that more efficient activators inhibit more strongly and that inhibition does not depend on the DNA-binding domain. We suggest that this inhibition, which we call squelching, reflects titration of a transcription factor by the activating region of
GAL4
.
...
PMID:Negative effect of the transcriptional activator GAL4. 341 49
We describe a new protein that binds to DNA and activates gene transcription in yeast. This protein, LexA-
GAL4
, is a hybrid of LexA, an Escherichia coli repressor protein, and
GAL4
, a Saccharomyces cerevisiae
transcriptional activator
. The hybrid protein, synthesized in yeast, activates transcription of a gene if and only if a lexA operator is present near the transcription start site. Thus, the DNA binding function of
GAL4
can be replaced with that of a prokaryotic repressor without loss of the transcriptional activation function. These results suggest that DNA-bound LexA-
GAL4
and DNA-bound
GAL4
activate transcription by contacting other proteins.
...
PMID:A eukaryotic transcriptional activator bearing the DNA specificity of a prokaryotic repressor. 1505 88
The nuclear oncoprotein v-Myb is a
transcriptional activator
in both animal cells and the budding yeast Saccharomyces cerevisiae. Previous studies have suggested that an acidic domain of approximately 50 amino acids (amino acids 204-254 of v-Myb) is necessary and sufficient for transcriptional activation by v-Myb, c-Myb and
GAL4
-Myb fusion proteins. However, we find that first, none of the acidic residues within this region is essential for transcriptional activation in either animal cells or yeast. Second, transcriptional activation requires cooperation among multiple domains of v-Myb. In animal cells, transcriptional activation by v-Myb requires a central domain (amino acids 234-295), a C-terminal domain (amino acids 295-356), plus either of two more N-terminal domains (amino acids 163-197 or 198-232); in yeast, it requires the central domain plus either the C-terminal domain or a more N-terminal domain (amino acids 163-233). Third, although various subsets of these domains are sufficient for transcriptional activation by v-Myb, all of the domains must be present for transformation of primary hematopoietic cells. These results demonstrate that transcriptional activation by v-Myb is not sufficient for oncogenic transformation.
...
PMID:Dissociation of transcriptional activation and oncogenic transformation by v-Myb. 747 5
The expression of the 7B2 protein, secreted from a variety of neural and endocrine tissues, increases dramatically in specific neuroendocrine tumors. We have recently shown that human 7B2 can act as a molecular chaperone in the deaggregation of proteins in vitro. In order to identify polypeptides which might bind 7B2 in vivo, the yeast two-hybrid system was employed. Surprisingly, mere covalent linkage of 7B2 to the DNA-binding domains of two yeast transcription activators, Ace1 and Gal4, activates transcription from the ACE1 and
GAL4
operon. 7B2's ability to activate nuclear transcription surpasses that of Ace1 and compares favourably with the strong activation domain of the tumor suppressor protein, p53. Our results suggest that 7B2 must possess an activating sequence, a domain which defines all
transcriptional activator
proteins. Like the acidic activation domains of some transcriptional activators, 7B2 also binds the yeast TATA-box binding protein, an essential polypeptide in the basic transcription machinery. Deletion analysis of the gene encoding 7B2 reveals two independent transcriptional activating sequences in the 185 amino acid protein. It is therefore conceivable that 7B2 not only has a functional role in the secretory pathway but also in the nucleus. Moreover, these findings raise an intriguing question regarding the activation domains of 7B2 and their possible link to 7B2's oncogenic potential.
...
PMID:The neuroendocrine protein 7B2 contains unusually potent transcriptional activating sequences. 748 73
Mutations in Vp1 and ABl3 genes of maize and Arabidopsis lead to drastic reductions in the synthesis of a subset of maturation-specific products including seed storage proteins. Gene Phaseolus vulgaris ABl3-like factor (PvAlf), whose protein product is similar to the ABl3 and Vp1 proteins, has been cloned. Here, it is shown that PvAlf positively regulates phaseolin and phytohemagglutinin (PHA-L) promoters in particle bombardment assays. PvAlf mRNA expression is embryo-specific and temporally complex. PvAlf mRNA abundance is highest during two periods (9-14 and 22-35 days after flowering) that precede the onsets of seed maturation and seed abscission, respectively. Protein fusions with the DNA-binding domain of the yeast
transcriptional activator
GAL4
demonstrated that the N-terminal 243 amino acids of PvAlf function as a strong transcriptional activation domain in yeast (Saccharomyces cerevisiae) and plant cells. This domain consists of a central cluster rich in serine, threonine and proline (STP cluster) flanked by two negatively charged regions containing bulky hydrophobic residues similar to acidic activation domains of Vp1, the herpes simplex virus virion protein VP16 and transcription factors GCN4 and HAP4 from yeast. Together with the Vp1 proteins of maize and rice and ABl3, PvAlf constitutes a class (Vp1/ABl3-like factors or VAlfs) of regulatory factors that are pivotal for the promotion of seed maturation and dormancy in angiosperms.
...
PMID:PvAlf, an embryo-specific acidic transcriptional activator enhances gene expression from phaseolin and phytohemagglutinin promoters. 755 Mar 72
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>